Circulating microRNAs: Promising candidates serving as novel biomarkers of acute hepatitis

Frontiers in Physiology

Volumn 3 DEC, Issue , 2012, Pages

  Elfimova, Natalia ^a   Schlattjan, Martin ^b   Sowa, Jan Peter ^b   Dienes, Hans Peter ^a   Canbay, Ali ^b   Odenthal, Margarete ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Acute liver failure; Extracellular miRNA; MicroRNA; MiR 122; MiRNA quantification; Spike in RNA

Indexed keywords

MICRORNA; MICRORNA 122; MICRORNA 181; MICRORNA 192; MICRORNA 21; MICRORNA 223; MICRORNA 26A; MICRORNA 92A; UNCLASSIFIED DRUG;

ACUTE HEPATITIS; ACUTE LIVER FAILURE; ARTICLE; BLOOD FLOW; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE MARKER; EXTRACELLULAR SPACE; GENE EXPRESSION REGULATION; HUMAN; NON INVASIVE MEASUREMENT; NONHUMAN; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTEIN AGGREGATION; QUANTITATIVE ANALYSIS; RNA ANALYSIS; RNA SEQUENCE; STANDARDIZATION;

EID: 84884164872     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00476     Document Type: Article

References (54)

1. Bala, S., Petrasek, J., Mundkur, S., Catalano, D., Levin, I., Ward, J., et al. (2012). Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology 56, 1946-1957.
2. Bartel, D. P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
3. Bartel, D. P. (2009). MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233.
4. Bernal, W., Auzinger, G., Sizer, E., and Wendon, J. (2008). Intensive care management of acute liver failure. Semin. Liver Dis. 28, 188-200.
5. Bihrer, V., Friedrich-Rust, M., Kronenberger, B., Forestier, N., Haupenthal, J., Shi, Y., et al. (2011). Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection. Am. J. Gastroenterol. 106, 1663-1669.
6. Burchard, J., Zhang, C., Liu, A. M., Poon, R. T., Lee, N. P., Wong, K. F., et al. (2010). microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma. Mol. Syst. Biol. 6:402. doi: 10.1038/msb.2010.58
7. Bushati, N., and Cohen, S. M. (2007). microRNA functions. Annu. Rev. Cell Dev. Biol. 23, 175-205.
8. Canbay, A., Chen, S. Y., Gieseler, R. K., Malago, M., Karliova, M., Gerken, G., et al. (2005). Overweight patients are more susceptible for acute liver failure. Hepatogastroenterology 52, 1516-1520.
9. Cermelli, S., Ruggieri, A., Marrero, J. A., Ioannou, G. N., and Beretta, L. (2011). Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS ONE 6:e23937. doi: 10.1371/journal.pone.0023937
10. Chen, C., Ridzon, D. A., Broomer, A. J., Zhou, Z., Lee, D. H., Nguyen, J. T., et al. (2005). Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 33:e179. doi: 10.1093/nar/gni178
11. Chen, C., Skog, J., Hsu, C. H., Lessard, R. T., Balaj, L., Wurdinger, T., et al. (2010). Microfluidic isolation and transcriptome analysis of serum microvesicles. Lab. Chip 10, 505-511.
12. Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., et al. (2008). Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18, 997-1006.
13. Cheung, O., Puri, P., Eicken, C., Contos, M. J., Mirshahi, F., Maher, J. W., et al. (2008). Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression. Hepatology 48, 1810-1820.
14. Cortez, M. A., and Calin, G. A. (2009). MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin. Biol. Ther. 9, 703-711.
15. Coulouarn, C., Factor, V. M., Andersen, J. B., Durkin, M. E., and Thorgeirsson, S. S. (2009). Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene 28, 3526-3536.
16. Ding, X., Ding, J., Ning, J., Yi, F., Chen, J., Zhao, D., et al. (2012). Circulating microRNA-122 as a potential biomarker for liver injury. Mol. Med. Rep. 5, 1428-1432.
17. Esau, C., Davis, S., Murray, S. F., Yu, X. X., Pandey, S. K., Pear, M., et al. (2006). miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 3, 87-98.
18. Gatfield, D., Le Martelot, G., Vejnar, C. E., Gerlach, D., Schaad, O., Fleury-Olela, F., et al. (2009). Integration of microRNA miR-122 in hepatic circadian gene expression. Genes Dev. 23, 1313-1326.
19. Gui, J., Tian, Y., Wen, X., Zhang, W., Zhang, P., Gao, J., et al. (2011). Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies. Clin. Sci. (Lond.) 120, 183-193.
20. Hadem, J., Stiefel, P., Bahr, M. J., Tillmann, H. L., Rifai, K., Klempnauer, J., et al. (2008). Prognostic implications of lactate, bilirubin, and etiology in German patients with acute liver failure. Clin. Gastroenterol. Hepatol. 6, 339-345.
21. Henke, J. I., Goergen, D., Zheng, J., Song, Y., Schuttler, C. G., Fehr, C., et al. (2008). microRNA-122 stimulates translation of hepatitis C virus RNA. EMBO J. 27, 3300-3310.
22. Hunter, M. P., Ismail, N., Zhang, X., Aguda, B. D., Lee, E. J., Yu, L., et al. (2008). Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE 3:e3694. doi: 10.1371/journal.pone.0003694
23. Ichai, P., and Samuel, D. (2008). Etiology and prognosis of fulminant hepatitis in adults. Liver Transpl. 14(Suppl. 2), S67-S79.
24. Ichai, P., and Samuel, D. (2011). Epidemiology of liver failure. Clin. Res. Hepatol. Gastroenterol. 35, 610-617.
25. Ji, F., Yang, B., Peng, X., Ding, H., You, H., and Tien, P. (2011). Circulating microRNAs in hepatitis B virus-infected patients. J. Viral. Hepat. 18, e242-e251.
26. Jopling, C. (2012). Liver-specific microRNA-122: biogenesis and function. RNA Biol. 9, 137-142.
27. Jopling, C. L. (2008). Regulation of hepatitis C virus by microRNA-122. Biochem. Soc. Trans. 36, 1220-1223.
28. Kim, D. J., Linnstaedt, S., Palma, J., Park, J. C., Ntrivalas, E., Kwak-Kim, J. Y., et al. (2012). Plasma components affect accuracy of circulating cancer-related microRNA quantitation. J. Mol. Diagn. 14, 71-80.
29. Lee, W. M. (2012). Acute liver failure. Semin. Respir. Crit. Care Med. 33, 36-45.
30. Kozomara, A., and Griffiths-Jones, S. (2011). miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 39, D152-D157.
31. Li, L. M., Hu, Z. B., Zhou, Z. X., Chen, X., Liu, F. Y., Zhang, J. F., et al. (2010). Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Res. 70, 9798-9807.
32. Lodes, M. J., Caraballo, M., Suciu, D., Munro, S., Kumar, A., and Anderson, B. (2009). Detection of cancer with serum miRNAs on an oligonucleotide microarray. PLoS ONE 4:e6229. doi: 10.1371/journal.pone.0006229
33. Miska, E. A. (2005). How microRNAs control cell division, differentiation and death. Curr. Opin. Genet. Dev. 15, 563-568.
34. Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., et al. (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U.S.A. 105, 10513-10518.
35. Morita, K., Taketomi, A., Shirabe, K., Umeda, K., Kayashima, H., Ninomiya, M., et al. (2011). Clinical significance and potential of hepatic microRNA-122 expression in hepatitis C. Liver Int. 31, 474-484.
36. Negrini, M., Gramantieri, L., Sabbioni, S., and Croce, C. M. (2011). microRNA involvement in hepatocellular carcinoma. Anticancer Agents Med. Chem. 11, 500-521.
37. Ng, E. K., Chong, W. W., Jin, H., Lam, E. K., Shin, V. Y., Yu, J., et al. (2009). Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58, 1375-1381.
38. Novellino, L., Rossi, R. L., Bonino, F., Cavallone, D., Abrignani, S., Pagani, M., et al. (2012). Circulating hepatitis B surface antigen particles carry hepatocellular microRNAs. PLoS ONE 7:e31952. doi: 10.1371/journal.pone.0031952
39. Qi, R., Weiland, M., Gao, X. H., Zhou, L., and Mi, Q. S. (2012). Identification of endogenous normalizers for serum microRNAs by microarray profiling: U6 small nuclear RNA is not a reliable normalizer. Hepatology 55, 1640-1642; author reply 1642-1643.
40. Renner, E. L. (2007). How to decide when to list a patient with acute liver failure for liver transplantation? Clichy or King's College criteria, or something else? J. Hepatol. 46, 554-557.
41. Resnick, K. E., Alder, H., Hagan, J. P., Richardson, D. L., Croce, C. M., and Cohn, D. E. (2009). The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol. Oncol. 112, 55-59.
42. Roderburg, C., Mollnow, T., Bongaerts, B., Elfimova, N., Vargas Cardenas, D., Berger, K., et al. (2012). Micro-RNA profiling in human serum reveals compartment-specific roles of miR-571 and miR-652 in liver cirrhosis. PLoS ONE 7:e32999. doi: 10.1371/journal.pone.0032999
43. Sarasin-Filipowicz, M., Krol, J., Markiewicz, I., Heim, M. H., and Filipowicz, W. (2009). Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. Nat. Med. 15, 31-33.
44. Shi, R., and Chiang, V. L. (2005). Facile means for quantifying microRNA expression by real-time PCR. Biotechniques 39, 519-525.
45. Skog, J., Wurdinger, T., Van Rijn, S., Meijer, D. H., Gainche, L., Sena-Esteves, M., et al. (2008). Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 10, 1470-1476.
46. Starkey Lewis, P. J., Dear, J., Platt, V., Simpson, K. J., Craig, D. G., Antoine, D. J., et al. (2011). Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology 54, 1767-1776.
47. Taylor, D. D., and Gercel-Taylor, C. (2008). MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol. Oncol. 110, 13-21.
48. Wang, K., Zhang, S., Marzolf, B., Troisch, P., Brightman, A., Hu, Z., et al. (2009). Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc. Natl. Acad. Sci. U.S.A. 106, 4402-4407.
49. Wang, S., Qiu, L., Yan, X., Jin, W., Wang, Y., Chen, L., et al. (2012). Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1)-modulated P53 activity. Hepatology 55, 730-741.
50. Xu, H., He, J. H., Xiao, Z. D., Zhang, Q. Q., Chen, Y. Q., Zhou, H., et al. (2010). Liver-enriched transcription factors regulate microRNA-122 that targets CUTL1 during liver development. Hepatology 52, 1431-1442.
51. Xu, J., Wu, C., Che, X., Wang, L., Yu, D., Zhang, T., et al. (2011). Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Mol. Carcinog. 50, 136-142.
52. Zhang, Y., Jia, Y., Zheng, R., Guo, Y., Wang, Y., Guo, H., et al. (2010). Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. Clin. Chem. 56, 1830-1838.
53. Zhao, Y., and Srivastava, D. (2007). A developmental view of microRNA function. Trends Biochem. Sci. 32, 189-197.
54. Zhou, J., Yu, L., Gao, X., Hu, J., Wang, J., Dai, Z., et al. (2011). Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J. Clin. Oncol. 29, 4781-4788.